Survivorship: Sexual dysfunction (male), version 1.2013 Journal Article
| Authors: | Denlinger, C. S.; Carlson, R. W.; Are, M.; Baker, K. S.; Davis, E.; Edge, S. B.; Friedman, D. L.; Goldman, M.; Jones, L.; King, A.; Kvale, E.; Langbaum, T. S.; Ligibel, J. A.; McCabe, M. S.; McVary, K. T.; Melisko, M.; Montoya, J. G.; Mooney, K.; Morgan, M. A.; O'Connor, T.; Paskett, E. D.; Raza, M.; Syrjala, K. L.; Urba, S. G.; Wakabayashi, M. T.; Zee, P.; McMillian, N.; Freedman-Cass, D. |
| Article Title: | Survivorship: Sexual dysfunction (male), version 1.2013 |
| Abstract: | Various anticancer treatments, especially those directed toward the pelvis, can damage blood vessels and reduce circulation of blood to the penis and/or damage the autonomic nervous system, resulting in higher rates of erectile dysfunction in survivors than in the general population. In addition, hormonal therapy can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for male sexual problems, namely erectile dysfunction. |
| Keywords: | radiotherapy; prevalence; erectile dysfunction; outcomes; sildenafil; men; cardiovascular-disease; localized prostate-cancer |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 12 |
| Issue: | 3 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2014-03-01 |
| Start Page: | 356 |
| End Page: | 363 |
| Language: | English |
| ACCESSION: | WOS:000332777600009 |
| PROVIDER: | wos |
| PUBMED: | 24616541 |
| PMCID: | PMC4465261 |
| Notes: | Review -- Source: Wos |
